Virus filtration with Virosart® is an integral part of the orthogonal virus clearance technology platform of Sartorius Stedim Biotech. This orthogonal technology platform features virus filtration, virus inactivation and virus adsorption. The Virosart® product range includes three different virus retentive membranes, in order to provide the best solution for every application.
Virosart® HC is the optimal virus filter for hydrophobic feed streams such as IVIG or any other blood & plasma product as well as hydrophobic antibodies and recombinant proteins (<150kDa). Virosart® HC is used at the end of the purification process for virus retentive filtration of the biopharmaceutical product. At this stage the purity of the biopharmaceutical product is the highest and virus filter blockage due to contaminants (DNA, CHOP, aggregates & lipoproteins) is the lowest.
Virosart® HC provides highest virus safety of the biopharmaceutical product. The filter retains more than 4 log10 of small non-enveloped viruses (e.g. PPV, MVM) and more than 6 log10 of large enveloped viruses (e.g. MuLV). Based on the unique double layer 20 nm PES membrane, Virosart® HC provides superior capacity even for hydrophobic, high blocking feed streams. This filter offers highest virus safety over the entire flow decay profile. The performance of the final virus filter mainly depends on the feed stream properties. Therefore, appropriate feed stream conditioning i.e. through efficient pre-filtration is a major aspect with the development of a virus filtration step.
Scale down work is realized using the Virosart® HC Minisart (5 cm2 capsule) to enable filtration work for flow and capacity studies as well as for GLP virus spiking studies. Scale up studies are performed using Virosart® HC capsule and|or MidiCaps® (240 cm2 | 2.700 cm2) to reliably scale up into larger scale manufacturing. Large scale manufacturing is operated with Virosart® HC MaxiCaps® or cartridges.
Virosart® HC filters are tested for integrity using a water based integrity test with the Sartocheck® technology of Sartorius Stedim Biotech. Virosart® HC filters have been validated for 4 log10 removal of small non-enveloped viruses using bacteriophage PP7 as the model virus. Validation data is shown in the validation guide of Virosart® HC. Each individual Virosart® HC filter is autoclaved and integrity tested during manufacture assuring highest product reliability. Virosart® HC filters are designed, developed and manufactured in accordance with a ISO 9001 certified Quality Management System. A Validation Guide is available for compliance with regulatory requirements.
Filter TypeVirus Filters
Filtration area0.27 m²
Connector Outlet¾" Tri-Clamp 25 mm
Connector Inlet¾" Tri-Clamp 25 mm
Primary Product TypeFilters
ApplicationBlood and Plasma